Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
Newly-released Pediatric Dental industry analysis report by Future Market Insights shows that global sales of Pediatric Dental in 2021 were held at US$ 9.6 Billion. With a CAGR of 7.4% from 2022 to 2032, the market is projected to reach a valuation of US$ 20.9 Billion by 2032. Market revenue through Dental Caries is expected to gross the highest revenue, accounting for an absolute dollar opportunity of nearly US$ 10.6 Billion from 2022 to 2032.
Attribute | Details |
---|---|
Global Pediatric Dental Market (2022) | US$ 10.3 Billion |
Global Pediatric Dental Market (2032) | US$ 20.9 Billion |
Global Pediatric Dental Market CAGR (2022 to 2032) | 7.4% |
USA Pediatric Dental Market (2022 to 2032) | 6.3% |
Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Pediatric Dental industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Pediatric Dental industry increased at around 6.2% CAGR, wherein, countries such as the USA, UK, China, Japan, and South Korea held a significant share in the global market. Owing to this, the pediatric dental market is projected to grow at a CAGR of 7.4% over the coming 10 years.
The advancement in technology of dental operations can be credited to the pediatric dental market's growth. Some of the children develop a dental fear that necessitates sedation dentistry as a safe and effective treatment option. Nitrous oxide is a type of general anesthesia that is increasingly being utilized in children's dentistry.
Pain-free mouth injections are used in pediatric dentistry to enhance the patient experience. The instruments and approaches are used to assist children to feel less pain and have less dental fear. This approach provides for faster treatments and higher patient cooperation.
Many people prefer a minimally invasive technique because of its advantages. CariVu, varnish, dental sealants, fluoride, and digital X-rays are examples of chemicals that can either intervene before restorative treatment or avoid dental disorders entirely. One of the noticeable developments in pediatric dentistry is the shift toward preventative care.
The American Academy of Pediatric Dentistry (AAPD) predicts that the growing number of pediatric dentists in America will boost by more than 60% within the next decade. Based on AAPD, the overall number of pediatric dentists practicing in the US has roughly doubled since 2001. Dental work as a pediatric dentist is anticipated to remain solid in the years to come, hence the industry's growth.
Over the projection period, Asia Pacific is expected to be the fastest-growing regional market. In the recent past, dental problems have gained significant attention in the Asia-Pacific countries. The surge in urbanization has led to the increasing expenditure of people on dental health. Besides, major players' investments in developing countries like China and India have boosted consumer confidence. In addition, the increasing prevalence of oral health diseases is expected to drive regional market expansion in the next years.
With a market share of more than 35% in 2021, the USA dominated the pediatric dental market. The vast patient base needed to fix varied dental health issues has ensured the success of dental work throughout the globe, like in the USA, and has contributed to the development of the healthcare ecosystem in many countries. According to Richmond Dental and Medical, the USA has 196,000 dentists. With the constant surge in the number of dental practitioners, the market in the country is expected to flourish in the forthcoming years.
The market in the UK is expected to reach a valuation of US$ 1.1 Billion by 2032. From 2022 to 2032, the market in the country is expected to gross an absolute dollar opportunity of US$ 561 Million, growing at a CAGR of 7.9%.
In Japan, the market is projected to reach US$ 848 Million by 2032, growing at a CAGR of 8% from 2022 to 2032. During the forecast period, the market is expected to gross an absolute dollar opportunity of US$ 457 Million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
With a share of revenue of more than 35% in 2021, the dental caries category led the market. The disarray among deciduous teeth is the result of more substantial dental problems. Infections, persistent pain, and other symptoms arise from dental caries in children. The condition of a kid's teeth at an early age affects his ability to discover social and emotional control. The need for treatment is likely to increase, as children get older. It will only be necessary to apply the remedy periodically to avoid an unhealthy lifestyle, and the affliction is projected to grow with future generations.
Dentists prefer to apply diet fluoride supplementation and fluoride varnish to the teeth of children who are at significant risk of dental caries as a preventive measure. Fluoride supplementation should be taken exactly as dental practitioners recommend. Early Childhood development of caries is a sugar-driven, multifactorial, bacterial-mediated kind of caries that causes phasic demineralization and remineralization of hard dental tissue. The therapy of early childhood caries (ECC) is expected to drive market expansion.
With a market share of more than 30% in 2021, the dental cleaning (prophylaxis) category led the market. The increase in the number of dental procedures carried out in dental facilities and hospitals is due to the rise in the number of dental prophylaxis treatments. Plaque that is untreatable through mass tooth brushing is removed with dental prophylaxis. The teeth must be cleaned at recurring intervals of about 8 to 16 weeks. This is more frequent for patients unable to clean their teeth themselves.
A yearly mouth debridement may be needed due to the accumulation of tartar. Hand tools, such as a micro-ultrasonic scaler are used during the procedure. Various antimicrobial treatments, periodontal disinfection, desensitizing gels, and full-mouth debridements are a few of the dental procedures available. Demand for such procedures is rising, due chiefly to a rise in oral hygiene problems, which will boost the segment's growth.
Malocclusion is a global dental issue that is on the rise. The most frequent dental problems encountered in children that are significantly associated with malocclusion are pulpal, dental trauma, dental caries, periapical lesions, oral habits, and developmental abnormalities. The segment's growth is expected to be boosted by the diagnosis and treatment of the condition.
In young toddlers with primary teeth, dental trauma is a regular occurrence. The greater physical mobility that comes with learning to walk and run is a big reason for this. Mandibular primary teeth are less vulnerable to trauma than anterior maxillary primary teeth. The most prevalent types of primary tooth injuries include luxation, avulsion, and crown fracture. The segment's expansion is likely to be fueled by the growing problem of dental trauma.
The market is fiercely competitive, with a large number of domestic and international companies. The key players operating in the market are 3M, Hu-Friedy Mfg. Co., LLC, Kinder Krowns, Figaro Crowns, Inc., Acero Crowns, Sprig Oral Health Technologies, Inc., Edelweiss Dentistry Products GmbH, SML, Cheng Crowns, and Dentsply Sirona.
Some of the recent developments of key Pediatric Dental providers are as follows:
Similarly, recent developments related to companies in Pediatric Dental Market have been tracked by the team at Future Market Insights, which are available in the full report.
The global Pediatric Dental market is worth more than US$ 10.3 Billion at present.
The value of Pediatric Dental is projected to increase at a CAGR of around 7.4% from 2022 to 2032.
The value of Pediatric Dental increased at a CAGR of around 6.2% from 2017 to 2021.
The top five players in Pediatric Dental market include 3M, Figaro Crowns, Hu-Friedy, Kinder Krowns, and Sprig Oral Health Technologies.
The top 5 countries driving demand for Pediatric Dental are the USA, the UK, China, Japan, and South Korea
Asia Pacific accounted for over 45% of global Pediatric Dental demand in 2021.
The European market for Pediatric Dental is projected to expand at a CAGR of around 19% from 2022 to 2032.
1. Executive Summary | Pediatric Dental Market 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Million) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Patch Management Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Patch Management Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032 6.1. Historical Market Analysis, 2017 to 2021 6.2. Current and Future Market Projections, 2022 to 2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021 7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Disease Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Disease Type, 2017 to 2021 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Disease Type, 2022 to 2032 8.3.1. Dental Caries 8.3.2. Enamel Disorders 8.3.3. Other Disease Types 8.4. Market Attractiveness Analysis By Disease Type 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By Type, 2017 to 2021 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type, 2022 to 2032 9.3.1. Primary 9.3.2. Permanent 9.4. Market Attractiveness Analysis By Type 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Procedure 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Procedure, 2017 to 2021 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Procedure, 2022 to 2032 10.3.1. Pulpotomies 10.3.2. Stainless Steel Crowns 10.3.3. Tooth-Colored Fillings 10.3.4. Dental Cleaning 10.3.5. Other Procedures 10.4. Market Attractiveness Analysis By Procedure 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2021 11.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Asia Pacific 11.3.5. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 12.4.1. By Country 12.4.1.1. United States of America 12.4.1.2. Canada 12.4.1.3. Rest of North America 12.4.2. By Disease Type 12.4.3. By Procedure 12.4.4. By Type 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Disease Type 12.5.3. By Procedure 12.5.4. By Type 13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Disease Type 13.4.3. By Procedure 13.4.4. By Type 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Disease Type 13.5.3. By Procedure 13.5.4. By Type 14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. France 14.4.1.3. United Kingdom 14.4.1.4. Italy 14.4.1.5. Benelux 14.4.1.6. Nordic Countries 14.4.1.7. Rest of Europe 14.4.2. By Disease Type 14.4.3. By Procedure 14.4.4. By Type 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Disease Type 14.5.3. By Procedure 14.5.4. By Type 15. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 15.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.1.4. Rest of Asia Pacific 15.4.2. By Disease Type 15.4.3. By Procedure 15.4.4. By Type 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Disease Type 15.5.3. By Procedure 15.5.4. By Type 16. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 16.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 16.4.1. By Country 16.4.1.1. GCC Countries 16.4.1.2. South Africa 16.4.1.3. Turkey 16.4.1.4. Rest of Middle East and Africa 16.4.2. By Disease Type 16.4.3. By Procedure 16.4.4. By Type 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Disease Type 16.5.3. By Procedure 16.5.4. By Type 17. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. US Market Analysis 17.2.1. Value Proportion Analysis by Market Taxonomy 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.2.2.1. By Disease Type 17.2.2.2. By Procedure 17.2.2.3. By Type 17.3. Canada Market Analysis 17.3.1. Value Proportion Analysis by Market Taxonomy 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.3.2.1. By Disease Type 17.3.2.2. By Procedure 17.3.2.3. By Type 17.4. Mexico Market Analysis 17.4.1. Value Proportion Analysis by Market Taxonomy 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.4.2.1. By Disease Type 17.4.2.2. By Procedure 17.4.2.3. By Type 17.5. Brazil Market Analysis 17.5.1. Value Proportion Analysis by Market Taxonomy 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.5.2.1. By Disease Type 17.5.2.2. By Procedure 17.5.2.3. By Type 17.6. Germany Market Analysis 17.6.1. Value Proportion Analysis by Market Taxonomy 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.6.2.1. By Disease Type 17.6.2.2. By Procedure 17.6.2.3. By Type 17.7. France Market Analysis 17.7.1. Value Proportion Analysis by Market Taxonomy 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.7.2.1. By Disease Type 17.7.2.2. By Procedure 17.7.2.3. By Type 17.8. Italy Market Analysis 17.8.1. Value Proportion Analysis by Market Taxonomy 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.8.2.1. By Disease Type 17.8.2.2. By Procedure 17.8.2.3. By Type 17.9. BENELUX Market Analysis 17.9.1. Value Proportion Analysis by Market Taxonomy 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.9.2.1. By Disease Type 17.9.2.2. By Procedure 17.9.2.3. By Type 17.10. UK Market Analysis 17.10.1. Value Proportion Analysis by Market Taxonomy 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.10.2.1. By Disease Type 17.10.2.2. By Procedure 17.10.2.3. By Type 17.11. Nordic Countries Market Analysis 17.11.1. Value Proportion Analysis by Market Taxonomy 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.11.2.1. By Disease Type 17.11.2.2. By Procedure 17.11.2.3. By Type 17.12. China Market Analysis 17.12.1. Value Proportion Analysis by Market Taxonomy 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.12.2.1. By Disease Type 17.12.2.2. By Procedure 17.12.2.3. By Type 17.13. Japan Market Analysis 17.13.1. Value Proportion Analysis by Market Taxonomy 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.13.2.1. By Disease Type 17.13.2.2. By Procedure 17.13.2.3. By Type 17.14. South Korea Market Analysis 17.14.1. Value Proportion Analysis by Market Taxonomy 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.14.2.1. By Disease Type 17.14.2.2. By Procedure 17.14.2.3. By Type 17.15. GCC Countries Market Analysis 17.15.1. Value Proportion Analysis by Market Taxonomy 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.15.2.1. By Disease Type 17.15.2.2. By Procedure 17.15.2.3. By Type 17.16. South Africa Market Analysis 17.16.1. Value Proportion Analysis by Market Taxonomy 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.16.2.1. By Disease Type 17.16.2.2. By Procedure 17.16.2.3. By Type 17.17. Turkey Market Analysis 17.17.1. Value Proportion Analysis by Market Taxonomy 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.17.2.1. By Disease Type 17.17.2.2. By Procedure 17.17.2.3. By Type 17.17.3. Competition Landscape and Player Concentration in the Country 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional footprint of Players 18.4.2. Product footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. 3M 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Sales Footprint 19.3.1.4. Strategy Overview 19.3.2. Figari Crowns 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Sales Footprint 19.3.2.4. Strategy Overview 19.3.3. Hu-friedy 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Sales Footprint 19.3.3.4. Strategy Overview 19.3.4. Kinder Crowns 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Sales Footprint 19.3.4.4. Strategy Overview 19.3.5. Sprig Oral Health Technologies 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Sales Footprint 19.3.5.4. Strategy Overview 19.3.6. Edelweiss Dentistry Products 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Sales Footprint 19.3.6.4. Strategy Overview 19.3.7. Acero Crowns 19.3.7.1. Overview 19.3.7.2. Product Portfolio 19.3.7.3. Sales Footprint 19.3.7.4. Strategy Overview 19.3.8. SML 19.3.8.1. Overview 19.3.8.2. Product Portfolio 19.3.8.3. Sales Footprint 19.3.8.4. Strategy Overview 19.3.9. Cheng Crowns 19.3.9.1. Overview 19.3.9.2. Product Portfolio 19.3.9.3. Sales Footprint 19.3.9.4. Strategy Overview 19.3.10. Dentsply Sirona 19.3.10.1. Overview 19.3.10.2. Product Portfolio 19.3.10.3. Sales Footprint 19.3.10.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million), By Disease Type, 2017 to 2021 Table 2: Global Market Value (US$ Million), By Disease Type, 2022 to 2032 Table 3: Global Market Value (US$ Million), By Procedure, 2017 to 2021 Table 4: Global Market Value (US$ Million), By Procedure, 2022 to 2032 Table 5: Global Market Value (US$ Million), By Type, 2017 to 2021 Table 6: Global Market Value (US$ Million), By Type, 2022 to 2032 Table 7: Global Market, By Region, 2017 to 2021 Table 8: Global Market, By Region, 2022 to 2032 Table 9: North America Market Value (US$ Million), By Disease Type, 2017 to 2021 Table 10: North America Market Value (US$ Million), By Disease Type, 2022 to 2032 Table 11: North America Market Value (US$ Million), By Procedure, 2017 to 2021 Table 12: North America Market Value (US$ Million), By Procedure, 2022 to 2032 Table 13: North America Market Value (US$ Million), By Type, 2017 to 2021 Table 14: North America Market Value (US$ Million), By Type, 2022 to 2032 Table 15: North America Market, By Country, 2017 to 2021 Table 16: North America Market, By Country, 2022 to 2032 Table 17: Latin America Market Value (US$ Million), By Disease Type, 2017 to 2021 Table 18: Latin America Market Value (US$ Million), By Disease Type, 2022 to 2032 Table 19: Latin America Market Value (US$ Million), By Procedure, 2017 to 2021 Table 20: Latin America Market Value (US$ Million), By Procedure, 2022 to 2032 Table 21: Latin America Market Value (US$ Million), By Type, 2017 to 2021 Table 22: Latin America Market Value (US$ Million), By Type, 2022 to 2032 Table 23: Latin America Market, By Country, 2017 to 2021 Table 24: Latin America Market, By Country, 2022 to 2032 Table 25: Europe Market Value (US$ Million), By Disease Type, 2017 to 2021 Table 26: Europe Market Value (US$ Million), By Disease Type, 2022 to 2032 Table 27: Europe Market Value (US$ Million), By Procedure, 2017 to 2021 Table 28: Europe Market Value (US$ Million), By Procedure, 2022 to 2032 Table 29: Europe Market Value (US$ Million), By Type, 2017 to 2021 Table 30: Europe Market Value (US$ Million), By Type, 2022 to 2032 Table 31: Europe Market, By Country, 2017 to 2021 Table 32: Europe Market, By Country, 2022 to 2032 Table 33: Asia Pacific Market Value (US$ Million), By Disease Type, 2017 to 2021 Table 34: Asia Pacific Market Value (US$ Million), By Disease Type, 2022 to 2032 Table 35: Asia Pacific Market Value (US$ Million), By Procedure, 2017 to 2021 Table 36: Asia Pacific Market Value (US$ Million), By Procedure, 2022 to 2032 Table 37: Asia Pacific Market Value (US$ Million), By Type, 2017 to 2021 Table 38: Asia Pacific Market Value (US$ Million), By Type, 2022 to 2032 Table 39: Asia Pacific Market, By Country, 2017 to 2021 Table 40: Asia Pacific Market, By Country, 2022 to 2032 Table 41: MEA Market Value (US$ Million), By Disease Type, 2017 to 2021 Table 42: MEA Market Value (US$ Million), By Disease Type, 2022 to 2032 Table 43: MEA Market Value (US$ Million), By Procedure, 2017 to 2021 Table 44: MEA Market Value (US$ Million), By Procedure, 2022 to 2032 Table 45: MEA Market Value (US$ Million), By Type, 2017 to 2021 Table 46: MEA Market Value (US$ Million), By Type, 2022 to 2032 Table 47: MEA Market, By Country, 2017 to 2021 Table 48: MEA Market, By Country, 2022 to 2032 Table 49: Global Market Incremental $ Opportunity, By Disease Type, 2017 to 2021 Table 50: Global Market Incremental $ Opportunity, By Procedure, 2022 to 2032 Table 51: Global Market Incremental $ Opportunity, By Type, 2017 to 2021 Table 52: Global Market Incremental $ Opportunity, By Region, 2022 to 2032 Table 53: North America Market Incremental $ Opportunity, By Disease Type, 2017 to 2021 Table 54: North America Market Incremental $ Opportunity, By Procedure, 2022 to 2032 Table 55: North America Market Incremental $ Opportunity, By Type, 2017 to 2021 Table 56: North America Market Incremental $ Opportunity, By Country, 2022 to 2032 Table 57: Latin America Market Incremental $ Opportunity, By Disease Type, 2017 to 2021 Table 58: Latin America Market Incremental $ Opportunity, By Procedure, 2022 to 2032 Table 59: Latin America Market Incremental $ Opportunity, By Type, 2017 to 2021 Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032 Table 61: Europe Market Incremental $ Opportunity, By Disease Type, 2017 to 2021 Table 62: Europe Market Incremental $ Opportunity, By Procedure, 2022 to 2032 Table 63: Europe Market Incremental $ Opportunity, By Type, 2017 to 2021 Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032 Table 65: Asia Pacific Market Incremental $ Opportunity, By Disease Type, 2017 to 2021 Table 66: Asia Pacific Market Incremental $ Opportunity, By Procedure, 2022 to 2032 Table 67: Asia Pacific Market Incremental $ Opportunity, By Type, 2017 to 2021 Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 to 2032 Table 69: MEA Market Incremental $ Opportunity, By Disease Type, 2017 to 2021 Table 70: MEA Market Incremental $ Opportunity, By Procedure, 2022 to 2032 Table 71: MEA Market Incremental $ Opportunity, By Type, 2017 to 2021 Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 to 2032
Figure 1: Global Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032 Figure 2: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 2032), US$ Million Figure 3: Global Market Share, By Disease Type, 2022 to 2032 Figure 4: Global Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032 Figure 5: Global Market Attractiveness Index, By Disease Type - 2022 to 2032 Figure 6: Global Market Share, By Procedure, 2022 to 2032 Figure 7: Global Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032 Figure 8: Global Market Attractiveness Index, By Procedure - 2022 to 2032 Figure 9: Global Market Share, By Type, 2022 to 2032 Figure 10: Global Market Y-o-Y Growth Projections, By Type - 2022 to 2032 Figure 11: Global Market Attractiveness Index, By Type - 2022 to 2032 Figure 12: Global Market Share, By Region, 2022 to 2032 Figure 13: Global Market Y-o-Y Growth Projections, By Region - 2022 to 2032 Figure 14: Global Market Attractiveness Index, By Region - 2022 to 2032 Figure 15: North America Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032 Figure 16: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million Figure 17: North America Market Share, By Disease Type, 2022 to 2032 Figure 18: North America Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032 Figure 19: North America Market Attractiveness Index, By Disease Type - 2022 to 2032 Figure 20: North America Market Share, By Procedure, 2022 to 2032 Figure 21: North America Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032 Figure 22: North America Market Attractiveness Index, By Procedure - 2022 to 2032 Figure 23: North America Market Share, By Type, 2022 to 2032 Figure 24: North America Market Y-o-Y Growth Projections, By Type - 2022 to 2032 Figure 25: North America Market Attractiveness Index, By Type - 2022 to 2032 Figure 26: North America Market Share, By Country, 2022 to 2032 Figure 27: North America Market Y-o-Y Growth Projections, By Country - 2022 to 2032 Figure 28: North America Market Attractiveness Index, By Country - 2022 to 2032 Figure 29: Latin America Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032 Figure 30: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million Figure 31: Latin America Market Share, By Disease Type, 2022 to 2032 Figure 32: Latin America Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032 Figure 33: Latin America Market Attractiveness Index, By Disease Type - 2022 to 2032 Figure 34: Latin America Market Share, By Procedure, 2022 to 2032 Figure 35: Latin America Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032 Figure 36: Latin America Market Attractiveness Index, By Procedure - 2022 to 2032 Figure 37: Latin America Market Share, By Type, 2022 to 2032 Figure 38: Latin America Market Y-o-Y Growth Projections, By Type - 2022 to 2032 Figure 39: Latin America Market Attractiveness Index, By Type - 2022 to 2032 Figure 40: Latin America Market Share, By Country, 2022 to 2032 Figure 41: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 2032 Figure 42: Latin America Market Attractiveness Index, By Country - 2022 to 2032 Figure 43: Europe Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032 Figure 44: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million Figure 45: Europe Market Share, By Disease Type, 2022 to 2032 Figure 46: Europe Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032 Figure 47: Europe Market Attractiveness Index, By Disease Type - 2022 to 2032 Figure 48: Europe Market Share, By Procedure, 2022 to 2032 Figure 49: Europe Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032 Figure 50: Europe Market Attractiveness Index, By Procedure - 2022 to 2032 Figure 51: Europe Market Share, By Type, 2022 to 2032 Figure 52: Europe Market Y-o-Y Growth Projections, By Type - 2022 to 2032 Figure 53: Europe Market Attractiveness Index, By Type - 2022 to 2032 Figure 54: Europe Market Share, By Country, 2022 to 2032 Figure 55: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 2032 Figure 56: Europe Market Attractiveness Index, By Country - 2022 to 2032 Figure 57: MEA Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032 Figure 58: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million Figure 59: MEA Market Share, By Disease Type, 2022 to 2032 Figure 60: MEA Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032 Figure 61: MEA Market Attractiveness Index, By Disease Type - 2022 to 2032 Figure 62: MEA Market Share, By Procedure, 2022 to 2032 Figure 63: MEA Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032 Figure 64: MEA Market Attractiveness Index, By Procedure - 2022 to 2032 Figure 65: MEA Market Share, By Type, 2022 to 2032 Figure 66: MEA Market Y-o-Y Growth Projections, By Type - 2022 to 2032 Figure 67: MEA Market Attractiveness Index, By Type - 2022 to 2032 Figure 68: MEA Market Share, By Country, 2022 to 2032 Figure 69: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 2032 Figure 70: MEA Market Attractiveness Index, By Country - 2022 to 2032 Figure 71: Asia Pacific Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032 Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million Figure 73: Asia Pacific Market Share, By Disease Type, 2022 to 2032 Figure 74: Asia Pacific Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032 Figure 75: Asia Pacific Market Attractiveness Index, By Disease Type - 2022 to 2032 Figure 76: Asia Pacific Market Share, By Procedure, 2022 to 2032 Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032 Figure 78: Asia Pacific Market Attractiveness Index, By Procedure - 2022 to 2032 Figure 79: Asia Pacific Market Share, By Type, 2022 to 2032 Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Type - 2022 to 2032 Figure 81: Asia Pacific Market Attractiveness Index, By Type - 2022 to 2032 Figure 82: Asia Pacific Market Share, By Country, 2022 to 2032 Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2022 to 2032 Figure 84: Asia Pacific Market Attractiveness Index, By Country - 2022 to 2032 Figure 85: US Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 86: US Market Share, By Disease Type, 2021 Figure 87: US Market Share, By Procedure, 2021 Figure 88: US Market Share, By Type, 2021 Figure 89: Canada Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 90: Canada Market Share, By Disease Type, 2021 Figure 91: Canada Market Share, By Procedure, 2021 Figure 92: Canada Market Share, By Type, 2021 Figure 93: Brazil Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 94: Brazil Market Share, By Disease Type, 2021 Figure 95: Brazil Market Share, By Procedure, 2021 Figure 96: Brazil Market Share, By Type, 2021 Figure 97: Mexico Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 98: Mexico Market Share, By Disease Type, 2021 Figure 99: Mexico Market Share, By Procedure, 2021 Figure 100: Mexico Market Share, By Type, 2021 Figure 101: Germany Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 102: Germany Market Share, By Disease Type, 2021 Figure 103: Germany Market Share, By Procedure, 2021 Figure 104: Germany Market Share, By Type, 2021 Figure 105: UK Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 106: UK Market Share, By Disease Type, 2021 Figure 107: UK Market Share, By Procedure, 2021 Figure 108: UK Market Share, By Type, 2021 Figure 109: France Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 110: France Market Share, By Disease Type, 2021 Figure 111: France Market Share, By Procedure, 2021 Figure 112: France Market Share, By Type, 2021 Figure 113: Italy Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 114: Italy Market Share, By Disease Type, 2021 Figure 115: Italy Market Share, By Procedure, 2021 Figure 116: Italy Market Share, By Type, 2021 Figure 117: BENELUX Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 118: BENELUX Market Share, By Disease Type, 2021 Figure 119: BENELUX Market Share, By Procedure, 2021 Figure 120: BENELUX Market Share, By Type, 2021 Figure 121: Nordic Countries Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 122: Nordic Countries Market Share, By Disease Type, 2021 Figure 123: Nordic Countries Market Share, By Procedure, 2021 Figure 124: Nordic Countries Market Share, By Type, 2021 Figure 125: China Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 126: China Market Share, By Disease Type, 2021 Figure 127: China Market Share, By Procedure, 2021 Figure 128: China Market Share, By Type, 2021 Figure 129: Japan Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 130: Japan Market Share, By Disease Type, 2021 Figure 131: Japan Market Share, By Procedure, 2021 Figure 132: Japan Market Share, By Type, 2021 Figure 133: South Korea Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 134: South Korea Market Share, By Disease Type, 2021 Figure 135: South Korea Market Share, By Procedure, 2021 Figure 136: South Korea Market Share, By Type, 2021 Figure 137: GCC Countries Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 138: GCC Countries Market Share, By Disease Type, 2021 Figure 139: GCC Countries Market Share, By Procedure, 2021 Figure 140: GCC Countries Market Share, By Type, 2021 Figure 141: South Africa Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 142: South Africa Market Share, By Disease Type, 2021 Figure 143: South Africa Market Share, By Procedure, 2021 Figure 144: South Africa Market Share, By Type, 2021 Figure 145: Turkey Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 146: Turkey Market Share, By Disease Type, 2021 Figure 147: Turkey Market Share, By Procedure, 2021 Figure 148: Turkey Market Share, By Type, 2021
Explore Healthcare Insights
View Reports